On September 8, 2023, the 2023 Chem Outsourcing was successfully concluded at Hilton Parsippany in New Jersey. The executive and business teams of Laviana Pharma were invited to participate in this event, and they shared Laviana Pharma's latest R&D achievements, cutting-edge technologies with industry colleagues from around the world, receiving widespread attention and praise.

As the largest exhibition for bulk pharmaceutical chemicals and pharmaceutical ingredients in the United States, the Chem Outsourcing has attracted 700 to 800 customers, project managers, executive managers and business developers from the pharmaceutical, biotech, chemical, and chemistry service industries from 30 countries. On this exhibition, raw materials, RSM, catalysts, drug discovery, process and chemical development, QA/QC, generics, etc. were presented, covering every link of the chemical supply chain.

Dr. Yang Guang, Chief Scientific Officer of Lavinia Pharma, was invited to participate in the round-table discussion of the Chem Outsourcing exhibition, one of the important sessions of the exhibition. In the discussion, he made in-depth discussions with the experts, scholars, industry colleagues, and business elites from around the world regarding the industry development, technology analysis and research achievements in combination with the business and actual cases of Laviana Pharma. The participants involved in the discussion expressed their high recognition and expectation for collaborations with Lavinia Pharma in the future.

In the future, Lavinia Pharma will continue to make in-depth discussions and share its achievements with more industry colleagues from the global. We will also continue to update our technology, optimize our service system, actively make explorations and innovations, and give full play to our experience and advantages in the field of small molecule CDMO, so as to meet the customization needs of global partners from laboratory to commercialization, promoting pharmaceutical innovation and development.